New York Life Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-18,351
| Closed | -$575K | – | 1329 |
|
|
2023
Q4 | $575K | Sell |
18,351
-538
| -3% | -$16.8K | 0.01% | 782 |
|
|
2023
Q3 | $394K | Sell |
18,889
-3,010
| -14% | -$62.7K | ﹤0.01% | 889 |
|
|
2023
Q2 | $524K | Sell |
21,899
-2,991
| -12% | -$71.6K | 0.01% | 691 |
|
|
2023
Q1 | $468K | Buy |
24,890
+1,468
| +6% | +$27.6K | 0.01% | 1094 |
|
|
2022
Q4 | $373K | Buy |
23,422
+2,639
| +13% | +$42K | ﹤0.01% | 1070 |
|
|
2022
Q3 | $340K | Buy |
20,783
+1,529
| +8% | +$25K | ﹤0.01% | 1047 |
|
|
2022
Q2 | $271K | Buy |
+19,254
| New | +$271K | ﹤0.01% | 1180 |
|